✦ LIBER ✦

A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY OF THE SAFETY AND TOLERANCE OF REGADENOSON IN PATIENTS WITH RENAL IMPAIRMENT

✍ Scribed by Karthikeyan Ananthasubramaniam; Robert Weiss; Barbara Klauke; Bruce McNutt; Kathleen Feaheny

Book ID: 118581459
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 243 KB
Volume: 57
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(11)60650-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study of the safety and tolerance of regadenoson in subjects with stage 3 or 4 chronic kidney disease

✍ Karthik Ananthasubramaniam; Robert Weiss; Bruce McNutt; Barbara Klauke; Kathleen 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 333 KB

A randomized, double-blind, placebo-cont

A randomized, double-blind, placebo-controlled study assessing the safety and tolerability of regadenoson in subjects with asthma or chronic obstructive pulmonary disease

✍ Bruce M. Prenner MD, Stan Bukofzer MBBCh, MMed (Int), Sarah Behm BS, Kathleen Fe 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 343 KB

Multicenter, randomized, placebo-control

Multicenter, randomized, placebo-controlled, double-blind study of the safety and efficacy of oral delapril in patients with congestive heart failure

✍ Antonio Circo; Francesco Platania; Salvatore Mangiameli; Ernesto Putignano 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 764 KB

Efficacy and safety of adalimumab in pat

Efficacy and safety of adalimumab in patients with ankylosing spondylitis: Results of a multicenter, randomized, double-blind, placebo-controlled trial

✍ Désirée van der Heijde; Alan Kivitz; Michael H. Schiff; Joachim Sieper; Ben A. C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 2 views

Safety and efficacy of esreboxetine in p

Safety and efficacy of esreboxetine in patients with fibromyalgia: A fourteen-week, randomized, double-blind, placebo-controlled, multicenter clinical trial

✍ Lesley M. Arnold; Ian Hirsch; Paul Sanders; Amanda Ellis; Bernadette Hughes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 171 KB

Long-Term Efficacy and Safety of Linagli

Long-Term Efficacy and Safety of Linagliptin in Patients With Type 2 Diabetes and Severe Renal Impairment: A 1-year, randomized, double-blind, placebo-controlled study

✍ McGill, J. B.; Sloan, L.; Newman, J.; Patel, S.; Sauce, C.; von Eynatten, M.; Wo 📂 Article 📅 2012 🏛 American Diabetes Association 🌐 English ⚖ 888 KB